These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38665055)

  • 1. The Impact of Infectious Mononucleosis History on the Risk of Developing Lymphoma and Nasopharyngeal Carcinoma: A Retrospective Large-Scale Cohort Study Using National Health Insurance Data in South Korea.
    Kang SH; Lee YH; Myong JP; Kwon M
    Cancer Res Treat; 2024 Oct; 56(4):1077-1083. PubMed ID: 38665055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sibship size, birth order and risk of nasopharyngeal carcinoma and infectious mononucleosis: a nationwide study in Sweden.
    Liu Z; Fang F; Chang ET; Adami HO; Ye W
    Int J Epidemiol; 2016 Jun; 45(3):825-34. PubMed ID: 25925268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
    Ji MF; Sheng W; Cheng WM; Ng MH; Wu BH; Yu X; Wei KR; Li FG; Lian SF; Wang PP; Quan W; Deng L; Li XH; Liu XD; Xie YL; Huang SJ; Ge SX; Huang SL; Liang XJ; He SM; Huang HW; Xia SL; Ng PS; Chen HL; Xie SH; Liu Q; Hong MH; Ma J; Yuan Y; Xia NS; Zhang J; Cao SM
    Ann Oncol; 2019 Oct; 30(10):1630-1637. PubMed ID: 31373615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.
    Lee MH; Huang YH; Coghill AE; Liu Z; Yu KJ; Hsu WL; Chien YC; Wang CP; Chen TC; Chen CJ; Hildesheim A
    J Infect Dis; 2021 Feb; 223(3):441-444. PubMed ID: 32614957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
    Hsu WL; Chien YC; Huang YT; Yu KJ; Ko JY; Lin CY; Tsou YA; Leu YS; Liao LJ; Chang YL; Su JY; Liu Z; Wang CP; Terng SD; Hua CH; Lee JC; Yang TL; Kate Hsiao CH; Wu MS; Tsai MH; Liu MJ; Lou PJ; Hildesheim A; Chen CJ;
    Cancer Med; 2020 Mar; 9(5):1867-1876. PubMed ID: 31925935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    Chen WJ; Xu WN; Wang HY; Chen XX; Li XQ; Xie SH; Lin DF; Cao SM
    BMC Cancer; 2021 Jun; 21(1):651. PubMed ID: 34074258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana.
    Ayee R; Ofori MEO; Tagoe EA; Languon S; Searyoh K; Armooh L; Bilson-Amoah E; Baidoo K; Kitcher E; Wright E; Quaye O
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32708700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.
    Kuri A; Jacobs BM; Vickaryous N; Pakpoor J; Middeldorp J; Giovannoni G; Dobson R
    BMC Public Health; 2020 Jun; 20(1):912. PubMed ID: 32532296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
    Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
    Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
    Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
    Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
    Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection.
    Okano M; Gross TG
    Am J Med Sci; 2012 Jun; 343(6):483-9. PubMed ID: 22104426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.
    Yang L; Kartsonaki C; Simon J; Yao P; Guo Y; Lv J; Walters RG; Chen Y; Fry H; Avery D; Yu C; Jin J; Mentzer AJ; Allen N; Butt J; Hill M; Li L; Millwood IY; Waterboer T; Chen Z
    Int J Epidemiol; 2024 Jun; 53(4):. PubMed ID: 39008896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation.
    Xu FH; Xiong D; Xu YF; Cao SM; Xue WQ; Qin HD; Liu WS; Cao JY; Zhang Y; Feng QS; Chen LZ; Li MZ; Liu ZW; Liu Q; Hong MH; Shugart YY; Zeng YX; Zeng MS; Jia WH
    J Natl Cancer Inst; 2012 Sep; 104(18):1396-410. PubMed ID: 22972969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
    Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
    EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.
    Liu S; Liu W; Zhao D; Zhang Y; Zhao Z; Luo B
    Oncol Res Treat; 2019; 42(11):572-579. PubMed ID: 31522169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Epstein-Barr virus infection with and without infectious mononucleosis.
    Rostgaard K; Balfour HH; Jarrett R; Erikstrup C; Pedersen O; Ullum H; Nielsen LP; Voldstedlund M; Hjalgrim H
    PLoS One; 2019; 14(12):e0226436. PubMed ID: 31846480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein-Barr Virus: An analysis of a prospective study in southern China.
    Hu T; Lin CY; Xie SH; Chen GH; Lu YQ; Ling W; Huang QH; Liu Q; Cao SM
    Cancer Med; 2019 May; 8(5):2561-2571. PubMed ID: 30843658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.